Universe Pharmaceuticals (UPC) Cash & Current Investments (2020 - 2025)

Universe Pharmaceuticals (UPC) has 6 years of Cash & Current Investments data on file, last reported at $33.6 billion in Q3 2025.

• For the quarter ending Q3 2025, Cash & Current Investments rose 8.8% year-over-year to $33.6 billion; the trailing twelve-month figure through Sep 2025 stood at $33.6 billion (up 8.8% YoY), and the FY2025 full-year result was $33.6 billion, up 8.8% from the prior year.
• Cash & Current Investments improved to $33.6 billion in Q3 2025, from $30.9 billion in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $33.6 billion in Q3 2025 to a low of $11.4 million in Q1 2024.
• A 5-year average of $9.4 billion and a median of $2.7 billion in 2022 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments surged 24355.18% in 2022 and tumbled 56.64% in 2024, its largest moves.
• Tracing UPC's Cash & Current Investments over 5 years: stood at $23.4 million in 2021, then surged by 24355.18% to $5.7 billion in 2022, then fell by 7.65% to $5.3 billion in 2023, then soared by 484.03% to $30.9 billion in 2024, then grew by 8.8% to $33.6 billion in 2025.
• Business Quant data shows UPC's Cash & Current Investments at $33.6 billion in Q3 2025, $30.9 billion in Q3 2024, and $11.4 million in Q1 2024.